French artificial heart maker Carmat will not carry out any more human transplants until it has determined the cause of the death of the first patient fitted with its device, one of the company’s co-founders said. Carmat’s first patient, a 76-year-old man, died on March 2 in Paris, two and a half months after his operation. Before he was fitted with the device, the man was suffering from terminal heart failure, when the sick heart can no longer pump enough blood to sustain the body, and was said to have only a few weeks, or even days, to live.
Help employers find you! Check out all the jobs and post your resume.
